Amgen Inc. (NASDAQ:AMGN) is set to announce third quarter earning results on Wednesday 28th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, AMGN to report 3Q20 income of $ 3.80 per share.
For the full year, analysts anticipate top line of $ 25411.00 million, while looking forward to income of $ 15.77 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 25,000.00 million ~ $ 25,600.00 million, where as bottomline are predicted in a range of $ 15.10 ~ $ 15.75 per share
Click Here For More Historical Outlooks Of Amgen Inc.
Previous Quarter Performance
Amgen Inc. announced income for the second quarter of $ 4.25 per share, from the revenue of $ 6,206.00 million. The quarterly earnings escalated 7.05 percent while revenues expanded 5.71 percent compared with the same quarter last year.
According to street consensus, AMGN was expected to report 2Q20 income of $ 3.84 per share from revenue of $ 6182.24 million. The bottom line results beat street analysts by $ 0.41 or 10.68 percent, at the same time, top line results outshined analysts by $ 23.76 million or 0.38 percent.
Stock Performance
Shares of Amgen Inc. traded low $ -1.43 or -0.64 percent on Tuesday, reaching $ 223.46 with volume of 1.93 million shares. Amgen Inc. has traded high as $ 225.90 and has cracked $ 223.14 on the downward trend
According to the previous trading day, closing price of $ 223.46, representing a 27.02 % increase from the 52 week low of $ 177.05 and a 15.13 % decrease over the 52 week high of $ 264.97.
The company has a market capital of $ 130.88 billion and is part of the Healthcare sector and Drug Manufacturers – Major industry.
Recent Analyst recommendations
- On 26th October 2020, upgraded by Raymond James to Outperform from Market Perform rating
- On 13th October 2020, maintained by Morgan Stanley at Overweight rating, with $ 273.00 target price.
- On 9th October 2020, downgraded by Bernstein to Market Perform from Outperform rating.
- On 6th October 2020, maintained by Oppenheimer at Outperform rating, with $ 280.00 target price.
Recent Stock Dividend Announcement
On July 23, 2020, the board of directors authorized quarterly dividend of $ 1.60 per share to holders of record as of the close of business on August 17, 2020, with payment date of September 8, 2020 and ex-dividend date on August 14, 2020.
Conference Call
Amgen Inc. will be hosting a conference call at 5:00 PM eastern time on 28th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.amgen.com
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, and neuroscience.
